Phase II randomized trial of carboplatin, paclitaxel, bevacizumab with or without cixutumumab (IMC-A12) in patients with advanced non-squamous, non-small-cell lung cancer: a trial of the ECOG-ACRIN Cancer Research Group (E3508)
卡铂、紫杉醇、贝伐珠单抗联合或不联合西妥珠单抗（IMC-A12）治疗晚期非鳞状非小细胞肺癌患者的 II 期随机试验：ECOG-ACRIN 癌症研究组 (E3508) 的一项试验
期刊:Annals of Oncology
影响因子:65.4
doi:10.1093/annonc/mdx534
Argiris, A; Lee, J W; Stevenson, J; Sulecki, M G; Hugec, V; Choong, N W; Saltzman, J N; Song, W; Hansen, R M; Evans, T L; Ramalingam, S S; Schiller, J H
